Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pertuzumab + Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer
NCT02004093Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2005
- Primary completion
- Sep 2008
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of pertuzumab in ovarian cancer, sponsored by Roche. Started Dec 2005; status: completed.
02
Drugs
pertuzumab
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02004093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004093.